U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need

Taking stock of the drug industry, from the lab to the medicine chest

December 5, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | U.K. to restrict Eli Lilly's obesity drug to patients with greatest need  The U.K. will soon offer Mounjaro for people with obesity — but only to a small share of those medically eligible, and with a special diet. By Andrew Joseph STAT+ | Change Healthcare cyberattack drives 2024 into another record year for health data breaches Nearly 172 million individuals — more than half the population of the U.S. — may have been impacted by large health data breaches in 2024. By Katie Palmer STAT+ | Atlas Venture completes 'disciplined' $450 million fundraise The same size as the firm's last fund, raised in 2022, this new fund will go toward 'venture creation' and startups across the therapeutic spectrum. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser